AAPL345.53-3.98 (-1.14%) ▼|ABBV290.88-3.95 (-1.34%) ▼|ABT113.35-2.16 (-1.87%) ▼|ACN267.23+2.96 (+1.12%) ▲|ADBE243.75-4.73 (-1.90%) ▼|AMAT325.91-43.49 (-11.77%) ▼|AMD416.58-72.20 (-14.77%) ▼|AMGN464.90-13.59 (-2.84%) ▼|AMT193.64-1.22 (-0.63%) ▼|AMZN259.82-6.22 (-2.34%) ▼|AVGO295.49-30.00 (-9.22%) ▼|AXP326.45-6.14 (-1.85%) ▼|BA171.91-5.10 (-2.88%) ▼|BAC50.11-1.52 (-2.94%) ▼|BKNG167.83-3.15 (-1.84%) ▼|BLK1,174.40-49.97 (-4.08%) ▼|BMY63.16-1.03 (-1.60%) ▼|BNY147.85-4.87 (-3.19%) ▼|BRK-B573.80-5.29 (-0.91%) ▼|C118.76-5.98 (-4.79%) ▼|CAT558.42-32.88 (-5.56%) ▼|CL98.81+0.05 (+0.05%) ▲|CMCSA24.81-0.05 (-0.18%) ▼|COF203.62-2.69 (-1.30%) ▼|COP137.51+0.57 (+0.42%) ▲|COST1,064.37+17.90 (+1.71%) ▲|CRM220.88-6.23 (-2.74%) ▼|CSCO96.04-7.57 (-7.31%) ▼|CVS80.35+0.39 (+0.48%) ▲|CVX215.74-1.22 (-0.56%) ▼|DE663.35-13.15 (-1.94%) ▼|DHR227.58-7.35 (-3.13%) ▼|DIS117.48-1.47 (-1.24%) ▼|DUK130.13+0.54 (+0.42%) ▲|EMR163.56-6.89 (-4.04%) ▼|FDX318.11-11.29 (-3.43%) ▼|GD358.91-5.96 (-1.63%) ▼|GE315.90-13.56 (-4.11%) ▼|GEV777.05-55.79 (-6.70%) ▼|GILD168.00-6.48 (-3.71%) ▼|GM89.14-3.29 (-3.56%) ▼|GOOG283.61-3.70 (-1.29%) ▼|GOOGL284.49-4.45 (-1.54%) ▼|GS871.57-56.43 (-6.08%) ▼|HD350.85-4.59 (-1.29%) ▼|HON216.94-11.53 (-5.05%) ▼|IBM247.77-6.55 (-2.58%) ▼|INTC53.58-4.69 (-8.05%) ▼|INTU351.82-4.82 (-1.35%) ▼|ISRG464.30-17.80 (-3.69%) ▼|JNJ272.50-3.82 (-1.38%) ▼|JPM337.31-14.80 (-4.20%) ▼|KO95.68-0.12 (-0.13%) ▼|LIN518.86-5.88 (-1.12%) ▼|LLY1,375.38-42.62 (-3.01%) ▼|LMT578.77-16.27 (-2.73%) ▼|LOW228.41-0.97 (-0.42%) ▼|LRCX190.22-31.22 (-14.10%) ▼|MA656.44-16.24 (-2.41%) ▼|MCD277.35-2.88 (-1.03%) ▼|MDLZ66.91-0.47 (-0.70%) ▼|MDT104.03-0.93 (-0.89%) ▼|META606.01-23.99 (-3.81%) ▼|MMM188.78-5.18 (-2.67%) ▼|MO77.34-0.67 (-0.86%) ▼|MRK147.31-3.05 (-2.03%) ▼|MS183.25-10.73 (-5.53%) ▼|MSFT535.26-20.54 (-3.70%) ▼|MU676.64-118.59 (-14.91%) ▼|NEE88.08-0.37 (-0.42%) ▼|NFLX64.88-1.52 (-2.28%) ▼|NKE39.45-1.05 (-2.58%) ▼|NOW102.06-6.75 (-6.20%) ▼|NVDA182.90-17.23 (-8.61%) ▼|ORCL115.23-8.50 (-6.87%) ▼|PEP143.42+1.00 (+0.70%) ▲|PFE30.09-0.70 (-2.27%) ▼|PG166.58-0.74 (-0.44%) ▼|PLTR155.02-16.68 (-9.71%) ▼|PM202.55-8.73 (-4.13%) ▼|QCOM158.93-14.26 (-8.23%) ▼|RTX192.54-5.89 (-2.97%) ▼|SBUX106.99-2.71 (-2.47%) ▼|SCHW92.64-0.73 (-0.78%) ▼|SO92.64-0.49 (-0.52%) ▼|SPG226.35-2.15 (-0.94%) ▼|T21.69-0.15 (-0.66%) ▼|TMO681.30-24.87 (-3.52%) ▼|TMUS159.77+0.60 (+0.38%) ▲|TSLA342.63-42.56 (-11.05%) ▼|TXN285.01-26.49 (-8.50%) ▼|UBER68.37-1.50 (-2.15%) ▼|UNH396.74-12.64 (-3.09%) ▼|UNP296.03-12.50 (-4.05%) ▼|UPS110.69-3.62 (-3.17%) ▼|USB59.48-1.55 (-2.54%) ▼|V424.45-12.12 (-2.78%) ▼|VZ46.12-0.06 (-0.12%) ▼|WFC84.48-2.95 (-3.37%) ▼|WMT128.11-1.06 (-0.82%) ▼|XOM167.58-1.70 (-1.00%) ▼|AAPL345.53-3.98 (-1.14%) ▼|ABBV290.88-3.95 (-1.34%) ▼|ABT113.35-2.16 (-1.87%) ▼|ACN267.23+2.96 (+1.12%) ▲|ADBE243.75-4.73 (-1.90%) ▼|AMAT325.91-43.49 (-11.77%) ▼|AMD416.58-72.20 (-14.77%) ▼|AMGN464.90-13.59 (-2.84%) ▼|AMT193.64-1.22 (-0.63%) ▼|AMZN259.82-6.22 (-2.34%) ▼|AVGO295.49-30.00 (-9.22%) ▼|AXP326.45-6.14 (-1.85%) ▼|BA171.91-5.10 (-2.88%) ▼|BAC50.11-1.52 (-2.94%) ▼|BKNG167.83-3.15 (-1.84%) ▼|BLK1,174.40-49.97 (-4.08%) ▼|BMY63.16-1.03 (-1.60%) ▼|BNY147.85-4.87 (-3.19%) ▼|BRK-B573.80-5.29 (-0.91%) ▼|C118.76-5.98 (-4.79%) ▼|CAT558.42-32.88 (-5.56%) ▼|CL98.81+0.05 (+0.05%) ▲|CMCSA24.81-0.05 (-0.18%) ▼|COF203.62-2.69 (-1.30%) ▼|COP137.51+0.57 (+0.42%) ▲|COST1,064.37+17.90 (+1.71%) ▲|CRM220.88-6.23 (-2.74%) ▼|CSCO96.04-7.57 (-7.31%) ▼|CVS80.35+0.39 (+0.48%) ▲|CVX215.74-1.22 (-0.56%) ▼|DE663.35-13.15 (-1.94%) ▼|DHR227.58-7.35 (-3.13%) ▼|DIS117.48-1.47 (-1.24%) ▼|DUK130.13+0.54 (+0.42%) ▲|EMR163.56-6.89 (-4.04%) ▼|FDX318.11-11.29 (-3.43%) ▼|GD358.91-5.96 (-1.63%) ▼|GE315.90-13.56 (-4.11%) ▼|GEV777.05-55.79 (-6.70%) ▼|GILD168.00-6.48 (-3.71%) ▼|GM89.14-3.29 (-3.56%) ▼|GOOG283.61-3.70 (-1.29%) ▼|GOOGL284.49-4.45 (-1.54%) ▼|GS871.57-56.43 (-6.08%) ▼|HD350.85-4.59 (-1.29%) ▼|HON216.94-11.53 (-5.05%) ▼|IBM247.77-6.55 (-2.58%) ▼|INTC53.58-4.69 (-8.05%) ▼|INTU351.82-4.82 (-1.35%) ▼|ISRG464.30-17.80 (-3.69%) ▼|JNJ272.50-3.82 (-1.38%) ▼|JPM337.31-14.80 (-4.20%) ▼|KO95.68-0.12 (-0.13%) ▼|LIN518.86-5.88 (-1.12%) ▼|LLY1,375.38-42.62 (-3.01%) ▼|LMT578.77-16.27 (-2.73%) ▼|LOW228.41-0.97 (-0.42%) ▼|LRCX190.22-31.22 (-14.10%) ▼|MA656.44-16.24 (-2.41%) ▼|MCD277.35-2.88 (-1.03%) ▼|MDLZ66.91-0.47 (-0.70%) ▼|MDT104.03-0.93 (-0.89%) ▼|META606.01-23.99 (-3.81%) ▼|MMM188.78-5.18 (-2.67%) ▼|MO77.34-0.67 (-0.86%) ▼|MRK147.31-3.05 (-2.03%) ▼|MS183.25-10.73 (-5.53%) ▼|MSFT535.26-20.54 (-3.70%) ▼|MU676.64-118.59 (-14.91%) ▼|NEE88.08-0.37 (-0.42%) ▼|NFLX64.88-1.52 (-2.28%) ▼|NKE39.45-1.05 (-2.58%) ▼|NOW102.06-6.75 (-6.20%) ▼|NVDA182.90-17.23 (-8.61%) ▼|ORCL115.23-8.50 (-6.87%) ▼|PEP143.42+1.00 (+0.70%) ▲|PFE30.09-0.70 (-2.27%) ▼|PG166.58-0.74 (-0.44%) ▼|PLTR155.02-16.68 (-9.71%) ▼|PM202.55-8.73 (-4.13%) ▼|QCOM158.93-14.26 (-8.23%) ▼|RTX192.54-5.89 (-2.97%) ▼|SBUX106.99-2.71 (-2.47%) ▼|SCHW92.64-0.73 (-0.78%) ▼|SO92.64-0.49 (-0.52%) ▼|SPG226.35-2.15 (-0.94%) ▼|T21.69-0.15 (-0.66%) ▼|TMO681.30-24.87 (-3.52%) ▼|TMUS159.77+0.60 (+0.38%) ▲|TSLA342.63-42.56 (-11.05%) ▼|TXN285.01-26.49 (-8.50%) ▼|UBER68.37-1.50 (-2.15%) ▼|UNH396.74-12.64 (-3.09%) ▼|UNP296.03-12.50 (-4.05%) ▼|UPS110.69-3.62 (-3.17%) ▼|USB59.48-1.55 (-2.54%) ▼|V424.45-12.12 (-2.78%) ▼|VZ46.12-0.06 (-0.12%) ▼|WFC84.48-2.95 (-3.37%) ▼|WMT128.11-1.06 (-0.82%) ▼|XOM167.58-1.70 (-1.00%) ▼|
21.4 C
New York
Thursday, November 5, 2026

Tag: year

BIRKS GROUP INC. REPORTS FISCAL 2025 RESULTS

MONTREAL, July 25, 2025 /CNW/ - Birks Group Inc. (the "Company" or "Birks Group") (NYSE American: BGI), today reported its financial results for the...

Barnes & Noble Education, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses

First Capital, Inc. Reports Quarterly Earnings

CORYDON, Ind., July 25, 2025 (GLOBE NEWSWIRE) -- First Capital, Inc. (the “Company”) (NASDAQ: FCAP), the holding company for First Harrison Bank (the “Bank”), today reported net income of $3.8 million, or $1.13 per diluted share, for the quarter ended June 30, 2025, compared to net income of $2.8 million, or $0.85 per diluted share, for the quarter ended June 30, 2024.

AMREP Reports Fiscal 2025 Results

HAVERTOWN, Pa., July 25, 2025 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today reported net income of $12,716,000, or $2.37 per diluted share, for its 2025 fiscal year ended April 30, 2025 compared to net income of $6,690,000, or $1.25 per diluted share, for the same period of the prior year. Revenues were $49,694,000 for fiscal 2025 and $51,369,000 for fiscal 2024.

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia

SOUTH SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- Recognify Life Sciences, a clinical-stage biotech company focused on developing treatments for cognitive impairment, today announced that its randomized, double-blind, placebo-controlled Phase 2b clinical trial evaluating inidascamine (formerly RL-007) in patients with cognitive impairment associated with schizophrenia (CIAS) did not meet its primary endpoint.

ASI Show Chicago 2025 Draws Nearly 5,000 Promo Pros to McCormick Place

TREVOSE, Pa., July 25, 2025 /PRNewswire/ -- The Advertising Specialty Institute® (ASI), the leading authority in the $26.6 billion promotional products industry, today announced...

NurExone Biologic Finalist in Falling Walls Venture 2025 Global Platform Showcasing The World’s Most Promising Science-Based Start-Ups

Company to compete for “Science Breakthrough of the Year” at Europe’s leading deep-tech summit in Berlin, Germany this November
Company to compete for “Science Breakthrough of the Year” at Europe’s leading deep-tech summit in Berlin, Germany this November

CAPR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Capricor Therapeutics, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Capricorn Therapeutics, Inc. (CAPR) Misled Investors Regarding the Viability of Deramiocel

ELIXIR MD, Inc. Expands into Mexico Through Strategic Partnership with Dr. Leonardo Moreno-Tevizo and Dr. Andrés Bello Margalef to Launch the Innovative ELIXIR MD™...

IRVINE, Calif. and MEXICO CITY, July 22, 2025 /PRNewswire/ -- ELIXIR MD, Inc., a pioneer in advanced aesthetic non-invasive medical technology and treatment protocols, is...

POP BIO and CEPI announce collaboration for faster responses to Disease X

Buffalo, NY, July 25, 2025 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a biotechnology company specializing in nanoparticle-based vaccines, and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced a new collaboration to accelerate the development of vaccines against future pandemic threats, including a potential ‘Disease X’. Backed by up to $1.5 million in funding from CEPI, the partnership will advance POP BIO’s SNAP™ (Spontaneous Nanoliposome Antigen Particleization) platform—a plug-and-play technology designed to enable rapid-response vaccine development through streamlined protein purification and nanoparticle delivery.

#BackToSchool Ready: YITAHOME’s Must-Have Collection

LONDON, July 25, 2025 (GLOBE NEWSWIRE) -- YITAHOME is excited to kick off its #BacktoSchool campaign, unveiling a fresh collection of smart, stylish, and space-saving furniture designed to meet the unique needs of students and families gearing up for the upcoming academic year. Available now on Amazon, this thoughtfully curated collection is all about maximizing space, reducing clutter, and keeping everything organized—without compromising on design or style. Whether it's for a dorm room, apartment, or home office, YITAHOME has the perfect solution for every student’s space.

Neon Bloom, Inc. Announces Successful Launch of AI-Driven Backend Software

Neon Bloom, Inc. Announces Successful Launch of AI-Driven Backend Software

Menovelle ‘Coffee Hack’ Fixes Hot Flashes, Belly Weight Gain & Mood Swings, Research Suggests

A Natural Supplement Trend in 2025, Menovelle Helps Women Support Hormonal Balance and Metabolic Energy Without Hormone Therapy or Stimulants
A Natural Supplement Trend in 2025, Menovelle Helps Women Support Hormonal Balance and Metabolic Energy Without Hormone Therapy or Stimulants

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsYear